Comparative genomic studies in primates have the potential to reveal the genetic and 18 mechanistic basis for human specific traits. These studies may also help us better understand 19
Introduction 44
Comparative studies of humans and non-human apes are extremely restricted because 45 we only have access to a few types of cell lines and to a limited collection of frozen tissues 46 (Romero et al. 2012) . In order to gain true insight into regulatory processes that underlie inter-47 species variation in complex phenotypes, we must have access to faithful model systems for a 48 wide range of tissues and cell types. To address this challenge, we previously established a 49 panel of iPSCs from human and chimpanzee fibroblasts (Gallego Romero et al. 2015; Burrows et 50 al. 2016 ; Blake et al. 2017 ). We can use this comparative iPSC panels to derive multiple cell types 51 representative of the three germ layers. For example, we recently differentiated the human and 52 chimpanzee iPSCs into definitive endoderm cells (Blake et al. 2017) to study conservation in 53 gene expression trajectories during early development. Our hope is that employing iPSC-based 54 models from humans and chimpanzees will provide researchers with a dynamic and flexible 55 system for comparative functional genomic studies in a large number of cell types. That said, these published works do not specifically address properties pertaining to the 68 utility of differentiated cardiomyocytes in the context of a comparative study in primates. First, 69 nearly all published studies were conducted using relatively few individuals (three or fewer), 70 such that the observation of high similarity of gene expression patterns between cultured cells 71 and primary tissue may be explained by lack of statistical power. Second, previous studies did 72 not consider their observations in the broader context of other tissues or other species, so it is 73 challenging to benchmark the observation of what is claimed to be 'small or 'large' regulatory 74 differences between tissues and cultured cells. Different protocols and batch effects make it 75 difficult to perform meta-analysis of existing data to effectively address this issue. Finally, to 76 date, no study that focused on the fidelity of differentiated cells included samples from 77
chimpanzees. 78
To address these gaps, we performed a comparative study that was specifically 79 designed to allow us to effectively compare gene expression data between cultured 80 cardiomyocytes and primary hearts from humans and chimpanzees. Our study was also 81 designed to allow us to benchmark the results against other primary tissues and across these 82 two species. A key finding from previous studies pertaining to the fidelity of iPSC-derived cell 83 types is the importance of cellular maturation after terminal differentiation. While the initial 84 steps of cardiomyocyte differentiation are fairly well established, there remains some debate in 85 the field as to the best method of cellular maturation (Veerman et (Nunes et al. 2013 ) and temporal 88 maturation in culture (Ivashchenko et al. 2013 ). The fidelity of cardiomyocytes to primary adult 89 heart tissue is likely to increase with cellular maturation. Thus, to test the effects of temporal 90 maturation and treatment with T3, we compared gene expression profiles from human and 91 chimpanzee iPSC-derived cardiomyocytes at day 15, day 27 (with and without T3 treatment) 92 post induction of differentiation with data generated from primary heart tissue from both 93 species. 94
95

Results
96
The primary goal of this work is not to test a particular hypothesis, but to develop an 97 understanding of the degree to which iPSC derived cardiomyocytes can serve as a model 98 system for comparative functional genomic studies in primates. To do so, we used matched 99 5 panels of 9 human and 10 chimpanzee iPSC lines; a subset of these iPSCs was previously 100 Table 1 ). Importantly, we found no significant difference in sample purity across species 113 (Supplemental Figure 4) . 114
We performed the cardiomyocyte differentiations in two batches, with partial sample 115 overlap across the batches; thus, our study contains technical replicates of differentiation for a 116 subset of samples. In the first experimental batch, we collected RNA on day 27 from samples 117 that were treated with T3. From the samples that were differentiated in the second batch, we 118 collected RNA from the iPSCs, from differentiated cardiomyocytes on day 15, and again on day 119 27, from samples that were either treated or not treated with T3. To benchmark the gene 120 expression data from the iPSC and iPSC-derived cardiomyocytes, we also collected RNA from 121 post-mortem flash frozen heart tissues samples from 21 chimpanzees and 11 humans 122 (Methods). Our overall study design (Supplemental Figure 4 ) affords us the flexibility to choose 123 to analyze different subsets of samples that are balanced with respect to different technical and 124 biological factors. We can thus effectively compare within and between species gene expression 125 data from primary tissue and iPSC-derived cardiomyocytes that were harvested on days 15 and 126 27, with or without the treatment T3. 127 6
We examined and recorded the quality of the RNA samples from both tissues and 128 cultures ( Supplemental Table 1 , Supplemental Figure 5 ), and sequenced each sample to an 129 average coverage of 49.4 million total reads. We mapped the sequencing reads to an updated 130 two-way human-chimpanzee orthologous exon reference set (Methods) and estimated relative 131 gene expression levels using edgeR ). Throughout the differentiation and 132 sample processing steps, we have recorded a large number of biological and technical 133
properties (sample metadata available in Supplemental Table 1 ). As a first step of our analysis, 134
we determined the potential impact of different properties of the study design and sample 135 metadata on the observed gene expression levels (using variance partitioning; Methods). Most 136 of the variation in our data can be explained by biological factors (species, day, and individual). 137
Most study design properties explain only a modest amount of variation, but as expected, 138 technical batch is associated with substantial amount of variation, as is sample purity (Figure 1 ). 139
Importantly, neither sample purity nor technical batch are associated with species 140 (Supplemental Figure 6) . 141 142
Which differentiated cardiomyocytes most resemble primary hearts? 143
Overall, we collected data from 110 samples (19 iPSCs, 59 differentiated cardiomyocytes, 144 and 32 primary heart samples). To examine global trends in gene expression levels, we 145 normalized data across all samples (using TMM; Methods), and visualized the data using 146 principal component analysis (PCA; Figure 2A ). We found that the major source of variation in 147 the data is correlated with cell type; PC1 and PC2, which explain 36% and 22% of the variance, 148 respectively, are highly associated with cell type (P < 10 -16 ). The next major source of variation, 149 as expected, is species (which is strongly associated with PC3; P < 10 -16 ). 150
We performed unsupervised hierarchical agglomerative clustering on the correlation 151 matrix of gene expression data, and found that the major trends seen in the PCA are 152 recapitulated ( Figure 2B ). We noted that data from iPSC-derived cardiomyocytes clusters by 153 species first, then by maturation day or treatment.
7
We focused on the differences between iPSC-derived cardiomyocytes at days 15 and 27, 155 with and without T3 treatment. For this analysis, we considered within-species gene expression 156 patterns. Using the data from each species independently, we asked which cardiomyocyte 157 cultures are most similar to adult heart tissue with respect to their gene expression profiles. We 158 first focused on temporal maturation (the untreated samples at days 15 and 27) and found that 159 average pairwise correlation in gene expression data is higher between untreated day 27 160 cardiomyocytes and hearts than between day 15 cardiomyocytes and hearts, regardless of 161 species ( Figure 3A , paired t-test; P < 10 -16 ). 162
This result indicates that temporal maturation increases the similarity between 163 cardiomyocytes and adult heart tissue for both species. We proceeded to compare gene 164 expression data between heart tissues and cardiomyocytes cultures at day 27 that were treated 165 or not treated with T3. We found that gene expression data from samples treated with T3 are 166 more similar to that of primary heart tissues, regardless of species ( Figure 3A , P < 10 -4 ). We 167 compared the maturation effects across species and found that, at day 15, human 168 cardiomyocytes are more similar to human adult heart tissue than chimpanzee cardiomyocytes 169 are to chimpanzee adult hearts ( Figure 3B , P < 10 -7 ). However, by day 27, we did not observe 170 any significant difference across species in this comparison (P = 0.13). 171 172
Which genes are differentially regulated between hearts and cultured cardiomyocytes? 173
Based on our observations we concluded that as the cells mature, the fidelity of iPSC-174 derived cardiomyocytes as a model for primary hearts increases in both species. Moreover, T3 175 treatment helps to mature iPSC-derived cardiomyocytes, altering their gene expression such 176 that it is more similar to that of adult tissues than temporal maturation alone. Yet, even T3 177 treated samples at day 27 are clearly distinct from heart samples (Figures 2 and 3 ). We thus 178 characterized the specific regulatory difference between heart tissues and iPSC-derived 179
cardiomyocytes. 180
To do so, we considered a subset of day 15 and T3 treated day 27 cardiomyocyte 181 samples from 7 humans and 7 chimpanzees, all with purity above 50% (Supplemental Figure 7) . 182
We used a linear model framework to perform a combined analysis of all data from these 183 samples, as well as from the corresponding iPSCs, and from the primary heart tissues 184 (Methods). We focused on genes that were classified as differentially expressed between cell / 185 tissue types in both humans and chimpanzees (Methods). At an FDR of 5% we classified 3,446 186 differentially expressed genes (of 13,878 orthologous genes) between samples at day 27 (T3 187 treated) and heart tissue, and 4,115 differentially expressed genes between samples at day 15 188 and heart tissue (Supplemental Table 2 ). For comparison, using the same approach, we 189 classified nearly 8,000 differentially expressed genes between iPSCs and cardiomyocytes at 190 either day 15 or day 27. 191
To gain insight into the processes that are differentially regulated between primary 192 hearts and iPSC-derived cardiomyocytes, we considered GO functional annotations (Ashburner 193 et al. 2000 ; The Gene Ontology 2017). We classified the differentially expressed genes between 194 hearts and cardiomyocytes to (i) those that are not expressed at all in hearts, (ii) or in 195 cardiomyocytes, and those that expressed in both tissues but are more highly expressed in (iii) 196 heart or (iv) cardiomyocytes. Among genes that are expressed in hearts but not in 197 cardiomyocytes, we found an almost exclusive enrichment for biological processes relating to 198 immune responses and inflammation. In turn, among genes that are expressed in 199 cardiomyocytes but not in hearts, we found enrichment of genes involved in cell cycle 200 regulation. Among genes expressed in both cardiomyocytes and hearts, we found that genes 201 involved in transcription regulation tend to be expressed at higher levels in cardiomyocytes and 202 genes involved in metabolic processes specifically related to lipid metabolism tend to be 203 expressed at higher levels in hearts ( Figure 4 ; complete enrichment results in Supplemental 204 Table 3 ; all reported enrichments associated with FDR < 0.05). Remarkably, when we consider 205 all of the enrichment results with FDR < 0.05, we are able to account for 67% of genes that are 206 classified as differentially expressed between hearts and iPSC-derived cardiomyocytes. 207
Up to this point, we considered gene expression patterns within species. To specifically 208 examine iPSC-derived cardiomyocytes as a model system for comparative genomic studies, we 209 proceeded to compare inter-species regulatory differences in either cell cultures or their 210 corresponding primary tissues. We used a framework of linear modeling as above, but this time 211 focused on the species by cell type interaction effect. To account for incomplete power when we 212 classified genes as differentially expressed between species in any given cell or tissue type, we 213 used a relaxed statistical cutoff for secondary observations. Namely, when a gene was classified 214 as differentially expressed between species in one cell or tissue type using a stringent statistical 215 cutoff (FDR of 5%), we used a relaxed statistical cutoff to classify the same gene as differentially 216 expressed between species in the other cell or tissue type (nominal P < 0.05; Methods). 217
Using this approach, we found that roughly 50% of genes that are classified as 218 differentially expressed between human and chimpanzee in heart tissues are also differentially 219 expressed between cultured cardiomyocytes of the two species, regardless of whether we 220 considered cardiomyocytes that were harvested at day 15 or day 27 ( Figure 5 ). This result is 221 robust with respect to the degree of purity of the cardiomyocyte cultures (within a range of 40-222 70%; Supplemental Figure 8 , Methods) and statistical stringency ( Supplemental Table 4 ). When 223 we considered genes that are classified as differentially expressed between the species either in 224 hearts or in cardiomyocytes (Methods), we found enrichment of similar functional terms when 225 we considered either the day 27 cardiomyocytes or the heart tissue samples (Supplemental 226   Table 5 ). Specifically, we found enrichment in terms relating to Carboxylic acid metabolism, 227 cellular adhesion and xenobiotic metabolic processes. When we considered genes that are 228 classified as differentially expressed between the species in both hearts and in cardiomyocytes, 229
we found an enrichment of terms relating to multiple different metabolic processes, including 230 monocarboxylic acid metabolic process, oxidation-reduction, and oxoacid metabolism 231 Table 5 
Cardiomyocytes are more similar to hearts than to other primary tissues 235
Our observations thus far indicate that while much of the heart regulatory divergence 236 between species can be captured by using iPSC-derived cardiomyocytes, there are also 237 thousands of genes whose expression differs between hearts and cultured cardiomyocytes. To 238 provide context for these observations, we used data from multiple publicly available RNA-seq 239 studies, which include samples from four different adult tissues from both humans and We first focused on similarities and differences between tissues and cell types. We 250 performed PCA using the combined data from all 342 samples, which suggested (based on 251 visual inspection) separation of the samples by cell and tissue type in the first several principal 252 components ( Figure 6A ; PC1 and PC2 are both highly associated with cell type or tissue type; P 253 < 10 -16 ). We only observed an association with species when we considered the loading on PC6 254 (P = < 10 -16 ). We next performed unsupervised hierarchical agglomerative clustering using the 255 correlation matrix of the combined gene expression data ( Figure 6B ). The samples clustered by 256 cell and tissue type followed by species (with the exception of public data from one chimpanzee 257 heart sample from (Peng et al. 2015) ). Notably, we found that samples from iPSC-derived 258 cardiomyocytes are consistently more similar to samples from fetal heart tissue, followed by 259 samples from adult heart tissues than any other non-heart tissues ( Figure 6B ). These 260 observations are consistent with previous findings that iPSC-derived cardiomyocytes are most 261 similar to first trimester fetal hearts (van den Berg et al. 2015). 262
We next evaluated the ability of iPSC-derived cardiomyocytes to capture regulatory 263 divergence in hearts in the context of comparative data sets from other tissues. To do so, we 264 used RNA-seq data collected from four individuals from each species from four different 265 tissues: heart, lung, liver and kidney (GEO accession GSE112356). We classified genes as 266 differentially expressed between human and chimpanzee in each tissue and in day 27 267 cardiomyocytes using a common analysis pipeline (Methods). To account for incomplete power 268 when classifying genes as differentially expressed between human and chimpanzee in any 269
given cell or tissue type, we again allowed for a more relaxed statistical cutoff for secondary 270 observations. As expected, a large number of genes show inter-species differences in gene 271 expression level across all tissues while different subsets of genes are differentially expressed 272 between the species in only a single tissue (Supplemental Figure 10) . Crucially, genes that are 273 differentially expressed between human and chimpanzee in cardiomyocytes are much more 274 likely to also be classified as differentially expressed between the species in hearts than in any 275 other tissue ( Figure 7) . The development of iPSC based model systems have the potential to transform the field 279 of comparative primate genomics, assuming that differentiated cells can recapitulate biological 280 processes that occur in primary cell types. Quite a few studies focused on gene regulatory 281 variation in in vitro differentiated cells have already been published (including by our group), 282 but a systematic assessment of the fidelity of these differentiated cells with respect to primary 283 primate tissue has not been performed. The current study was therefore designed to specifically 284 assess the degree to which differentiated cardiomyocytes can serve as a model system in which 285
to study regulatory differences in human and chimpanzee hearts. 286
We debated which cell type to use for this first exploration of the fidelity of 287 provide an optimal framework to begin characterizing the similarity of iPSC-derived cell types 300 to primary tissue in primates. 301
We did not expect differentiated cardiomyocytes to be identical to hearts. That would 302 not be a realistic expectation. We hoped that differentiated cardiomyocytes would be the most 303 similar to hearts over than to any other tissue, and we hoped to shed light on the opportunities 304 and limitations associated with the use of differentiated cardiomyocytes to study hearts. Our 305 observations confirmed that gene expression data from differentiated cardiomyocytes are more 306 similar to data from hearts than any other tissue we tested, but we also found thousands of 307 differentially expressed genes between hearts and differentiated cardiomyocytes. The majority 308 of these differentially expressed genes, however, may not point to inherent limitations of 309 differentiated cardiomyocytes as a model, but rather they help us better understand the model 310
properties. 311
Indeed, 67% of differentially expressed genes between hearts and differentiated 312 cardiomyocytes may be explained, not by artifacts specific to the model, but by expected 313 biological differences between in vitro cultured relatively pure cells and a complex primary cardiac fibroblasts, endothelial cells, blood cells and resident immune cells. It is therefore 325 reasonable that genes involved in immune responses and inflammation are highly expressed in 326 hearts compared with differentiated cardiomyocytes. Finally, it has been previously reported 327 that the metabolic state of hearts and cultured cardiomyocytes are different (Uosaki et al. 2015) . 328
Consistent with that report, we found that genes involved in lipid metabolism are highly 329 expressed in hearts relative to differentiated cardiomyocytes, an expected observation given 330 that our cell cultures were not supplemented with lipids. Thus, the majority of the thousands of 331 differentially expressed gene between primary hearts and cardiomyocytes are not necessarily 332 indicative of inherent limitations of the in vitro model. Rather, many of these regulatory 333 differences point to biological (cell composition) and environmental (lipids) differences between 334 cell culture and primary tissue. 335
When we specifically considered inter-species comparisons of gene expression levels 336 using either cardiomyocytes or hearts, we found similar patterns. Namely, while most genes are 337 classified as differentially expressed between humans and chimpanzee in both differentiated 338 cardiomyocytes and hearts, thousands of genes are differentially expressed between the species 339 in either hearts or cardiomyocytes. Yet, the discordant inter-species patterns in cardiomyocytes 340 and hearts mostly involve genes with functions related to metabolic processes, regulation of 341 gene expression, and cell cycle. As we discussed above, there are likely biological and 342 environmental explanations to these patterns. 343
We thus conclude that iPSC-derived cardiomyocytes are a useful model with which to 344 conduct comparative studies of gene regulation. We expect that iPSC-derived cardiomyocytes 345 will be mainly used to comparatively study dynamic gene regulatory processes, such as during 346 differentiation, when frozen heart samples -even when available -are unsuitable. The model is 347 not perfect, but our study indicates that regulatory patterns observed in cultured 348 cardiomyocytes cannot be mistaken as anything other than a representation of the biological 349 processes that occur in primary hearts. With that in mind, we recommend that the data from 350 our study, which are available in unprocessed and processed forms, should be used to evaluate 351 the likelihood that future observations based on cultured cardiomyocytes faithfully represent 352 regulatory patterns in primary heart tissues. Media was changed every 48 hours until cells were harvested at day 27 (total of 3 additional 402 media changes). For the first two media changes (Days 0 and 2) cultures were supplied with an 403 excess of media (0.499 mL/cm 2 ), all other days' media was added at (0.2495 mL/cm 2 ). 404 405
Determining iPSC-derived cardiomyocyte purity using flow cytometry 406
Day 15 cells were dissociated as described above, and aliquots were pulled off for flow 407 analysis prior to replating. Day 27 iPSC-derived cardiomyocytes were dissociated by 10 minute 408 incubations with TrypLE supplemented with 0.5 U/ml Liberase TH. Dissociated cells were 409 centrifuged at 200 x g for 5 minutes at 4C and washed with PBS. Cells were fixed and stained 410 as specified previously (Burridge et al. 2014; Burridge et al. 2015) . Briefly, 0.5-1 million cells 411 were fixed using a 1% PFA solution. Cells were fixed at 4C for 30 minutes before washing once 412 using FACS buffer (autoMACS Running Buffer, Miltenyi Biotech). Fixed cells were 413 permeabilized by incubating with cold 90% methanol for 30 minutes at 4C. Fixed, 414 permeabilized cells were washed 2x using FACS buffer prior to staining. For immunostaining, 415 150,000 cells were transferred to BRAND lipoGrade 96 well immunostaining plates and 416 
Isolation of RNA and DNA 431
To isolate RNA and DNA from cardiomyocytes and iPSC lines, we first aspirated old 432 cell culture media, then rinsed culture wells using PBS. After aspirating PBS, 300 μL of 433 DNA/RNA lysis buffer was added directly to culture plates to lyse cells on the plate. The entire 434 lysate was transferred to a 1 mL tube and immediately frozen for extraction with other samples 435 in balanced batches. We extracted the RNA using the ZR-Duet DNA/RNA MiniPrep kit (Zymo) 436
with the addition of an on column DNAse I treatment step prior to RNA elution. 437
Post-mortem human heart tissues were provided by the National Disease Research 438
Interchange (NDRI). Chimpanzee post-mortem heart tissues were provided by Yerkes primate 439 center, the Southwest Foundation for Biomedical Research, and the New Iberia Research Center, 440 MD Anderson Cancer Center. For lysis of heart tissue, frozen tissue from the left ventricle was 441 broken down into smaller chunks while working on dry ice to prevent thawing, and 442 subsequently weighed in 1.5 mL tubes to determine weight of tissue. For each mg of tissue, we 443 added 8 μL of 1X RNA/DNA shield buffer. Tissues were homogenized in RNA/DNA shield 444 using sterile plastic pestles. To further homogenize tissues and release RNA and DNA, tissues 445 were digested with Proteinase K for 30 minutes at 55C. Digested, homogenized tissues were 446 centrifuged for 2 minutes to pellet debris, the volume of supernatant was measured and was 447 transferred to fresh tubes. An equal volume of DNA/RNA lysis buffer was added and the 448 solution was mixed prior to freezing at -80. Frozen samples were thawed and extracted in 449 parallel using the same protocol as used for cells. 450 451
Sequencing library preparation and RNA sequencing 452
We used non-strand specific, polyA capture to generate RNA-seq libraries according to 453 the Illumina TruSeq protocol. To estimate the RNA concentration and quality, we used the 454 Agilent 2100 Bioanalyzer. We added barcoded adaptors (Illumina TruSeq RNA Sample 455 Preparation Kit v2) and sequenced the 100 base pair single-end RNA-seq libraries on the 456
Illumina HiSeq 4000 at the Functional Genomics Core at University of Chicago on two flow 457 cells. We used FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) to confirm 458 that the reads were high quality. 459 460
Mapping of RNA-seq data, orthologous exons, read count transformation and normalization 461
We mapped human reads to the hg38 genome and chimpanzee reads to panTro5 using 462 HISAT2 (Kim et al. 2015) using the default parameters. We kept on only reads that mapped 463 uniquely. To prevent biases in expression level estimates due to differences in mRNA transcript 464 size and the relatively poor annotation of the chimpanzee genome and differences in 465 mappability between species, we only kept reads that mapped to a list of orthologous 466 metaexons. As the previous version of this metaexon database was generated using older 467 versions of the genomes, we generated an updated orthoexon database based on the most 468 current genome builds (see methods below for details). Gene expression levels were quantified 469 using the FeatureCounts function in SubRead (version 1.5.1, (Liao et al. 2014) We performed all 470 downstream processing and analysis steps in R unless otherwise stated. 471
We used a common analysis pipeline to process RNA sequencing data collected from the 472 current study and also from the downloaded public datasets. We transformed raw gene counts 473 into log2-transformed counts per million (CPM) using edgeR ). To filter for 474 the lowly expressed genes, we kept only genes with an average expression level of log2(CPM) > 475 2 in at least one cell type (Robinson and Oshlack 2010) . For the remaining genes, we normalized 476 the read counts using the weighted trimmed mean of M-values algorithm (TMM) (Robinson 477 and Oshlack 2010) to account for between-sample differences in the read counts at the extremes 478 As part of the work contained in this paper, we updated our previously generated exon 492 database (Blekhman 2012) with slight modification. We describe the modifications as follows. 493
First, exon definitions were initially obtained from Ensembl release 88 (downloaded March 2017 494 containing 744,360 exons across 63,898 genes). This initial set of exon definitions was condensed 495 to remove redundancies (haplotypes, patches and alternate exon entries resulting from different 496 source annotations) and exons from genes that were fully overlapping. Regions of exons 497 containing overlaps belonging to different genes were removed; exons with at least 10 bp of 498 sequence not contained within the overlapping region were retained by removing only the 499 region of overlap. This resulted in the division up of some exons into one or more smaller 500 unique exons. Exons for the same genes with overlaps of at least 1 bp were collapsed into single 501 metaexons containing all overlapping exons. Human fasta sequences (for the reduced set of 502 320,753 meta exons across 56,479 genes) were then extracted from the genome (Ensembl 503
GRCh38.p10). We then used BLAT (BLAT V. 35 (Kent 2002) ) to identify the orthologous exon 504 sequences in the chimpanzee genome (panTro5). All hits with indels larger than 25 bp were 505 removed (using a function blatOutIndelIdent, from 506 https://bitbucket.org/ee_reh_neh/orthoexon), the fasta sequences for the hits with the highest 507 sequence identity were extracted from the genome (using Bedtools (Quinlan and Hall 2010)). 508
The chimpanzee sequences were then blatted against the human genome and back to the 509 chimpanzee genome. Queries that did not return the original blat locations (for either 510 chimpanzee or human) were removed, as were entries where multiple possible mappings 511 occurred with higher than 90% sequence identity. Finally, different exons mapping to the same 512 location (different locations in human, but same location in chimpanzee) were removed. This 513 updated human-chimpanzee orthologous exon database resulted in 254,172 metaexons across 514 44,125 genes and is provided as Supplemental File 1. 515 516
Linear modeling, differential expression and gene enrichment analyses 517
Differential expression analysis was performed using an empirical Bayes approach to 518 linear modeling in genome wide expression data implemented in the R package limma (Smyth 519 2004; Smyth et al. 2005) . To apply this linear modeling approach to RNA-seq read counts, we 520 calculated weights that account for the mean-variance relationship of the count data using the 521 function voom from the limma package (Law et al. 2014) . 522
In analyses with both tissue and iPSC-derived cardiomyocytes, we cannot correct for 523 purity differences, thus, we chose iPSC-derived cardiomyocytes with the highest purity 524 Table 1 ). Since RNA quality varied greatly between tissues and derived cells 525 Table 1 , Supplemental Figure 5 ), we modeled RNA quality as a fixed effect using 526 RIN scores. For all pairwise differential expression comparisons, the species, cell type, RNA 527 quality (RIN), and a species-by-cell type interaction were modeled as fixed effects, and 528 individual as a random effect. We used contrast tests in limma to find genes that were 529 differentially expressed between tissues and cells for each species. For each pairwise 530 differentially expressed (DE) test, we corrected for multiple testing with the Benjamini & 531 Hochberg false discovery rate (Benjamini and Hochberg 1995) and genes with an FDR-adjusted 532 P values < 0.05 were considered DE. 533
To identify genes as shared or specific to one species when examining DE genes between 534 different cell or tissue types while accounting for incomplete power to detect overlaps, we first 535 identified DE genes between the different cell or tissue types at an FDR of 5% in each species 536 separately. Using this list of significant DE genes, we then looked in the other species, but 537 classified genes as DE with a more relaxed cut off using a nominal P value of 0.05. Genes 538 identified at an FDR of 5% in one species but not significant at a nominal P value of less than 539 0.05 in the other species were determined to be specific to one species. Genes that were 540 significant in one species at FDR of 5% and significant at a nominal P value of less than 0.05 in 541 22 the other species were designated as shared. This same approach was also taken when looking 542 at interspecies DE genes in heart tissue or iPSC-derived cardiomyocytes. 543
When examining the overlap of interspecies DE genes in multiple different tissues, data 544
for each tissue or cell type was modeled separately, as all data could not be modeled together 545 due to differences in sequencing technology (50 bp Illumina GAIIx vs 100 bp Illumina HiSeq 546 4000). For this analysis, we only included terms for species and RNA quality (RIN score). To 547 identify shared interspecies DE genes across different tissues and cell types while accounting 548 for incomplete power to detect overlaps, we used the same approach as detailed above. 549
To identify significantly enriched GO biological process terms for genes DE between day 550 27 cardiomyocytes and heart tissue, we used the compareCluster function implemented in the R 551 package clusterProfiler (version 3.4.4, (Yu et al. 2012) ). We used all expressed genes as our 552 background for enrichment and only considered GO terms containing more than three 553 annotated genes and less than 3000 genes. When considering all interspecies differentially 554 expressed genes in heart tissues or day 27 samples, we found no significantly enriched GO 555 terms. Results in the main text were derived from GO analysis using genes with an absolute 556 log2-fold change between human and chimpanzee higher than 1.5. 557 558
Determining how purity differences affect estimates of interspecies DE gene overlaps 559
Since target cell type heterogeneity may vary within tissues and cannot be easily 560 assessed, we were interested in the effect of purity on our ability to detect interspecies tissue 561 specific DE patterns using iPSC-derived cardiomyocytes. As we are unable to physically alter 562 (or effectively estimate) the composition of post mortem tissues, we instead used different 563 combinations of T3 treated day 27 cardiomyocyte samples to generate 277 different average 564 purity scenarios (Supplemental Figure 11) . With each combination of samples, we repeated the 565 same analysis as described in the main text to determine how many interspecies DE genes 566 identified in heart tissue could be recapitulated using iPSC-derived cardiomyocytes. 567 568 Acknowledgment 569
We thank Michelle Ward, Joyce Hsiao and other members of the Gilad lab for helpful 570 discussions and comments on the manuscript. This work was supported by NIH grants 571 Figure 4 . Gene enrichment analysis. We classified differentially expressed genes as those that are expressed at higher level ('Higher Expression') in either primary hearts or the iPSC-derived cardiomyocytes, and further, to those that are practically not expressed ('Above Threshold') in either primary hearts or the cardiomyocytes (see main text for more details). The top enrichments in GO biological processes for each of the categories is shown, gene list sizes are shown under the label for each gene set. Complete GO enrichment results are available in Supplemental Table 3 . samples. Karyotypes for human (right) and chimpanzee lines (left) used in this study. We identified additional bands in the p-arms of one chromosome 13 homolog and one chromosome 18 homolog for chimpanzee iPSC line C3. Thus, we tested the source fibroblast line (C3 FB) to determine that these polymorphisms were normal polymorphisms and not formed de novo as a result of reprogramming.
